|Articles|July 2, 2015

Jennifer Klemp on Survivorship for Patients With Hereditary Breast Cancer

Author(s)Jennifer Klemp, Ph.D., M.P.H.

Jennifer Klemp, PhD, MPH, director, Breast Cancer Survivorship Center, The University of Kansas Cancer Center, discusses survivorship for patients with hereditary breast cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

FDA Accepts Gedatolisib Application for Some With Breast Cancer

ByAlex Biese

January 21st 2026

Active Lifestyle Changes Following an MDS Diagnosis

ByRichard "Rocky" Kimball

January 20th 2026

Dr. Nicholas Hornstein explained the concept of ctDNA and how this blood test may help guide treatment decisions, including whether additional therapy is needed.

What Is ctDNA, and How Does It Guide Treatment Decisions?

ByDr. Nicholas Hornstein

January 20th 2026

Patients With Thyroid Cancer Can Discuss Clinical Trials ‘From the Get-Go’

ByDr. Robert Alter

January 20th 2026

During the Blood Cancer Heroes Event, Joe McDonough shared his excitement at being among individuals making meaningful contributions to others’ lives.

Humility and Impact in Joe McDonough’s Blood Cancer Heroes Experience

ByJoe McDonough

January 20th 2026

Jennifer Klemp on Survivorship for Patients With Hereditary Breast Cancer

Newsletter

Related Content

FDA Accepts Gedatolisib Application for Some With Breast Cancer

Active Lifestyle Changes Following an MDS Diagnosis

What Is ctDNA, and How Does It Guide Treatment Decisions?

Patients With Thyroid Cancer Can Discuss Clinical Trials ‘From the Get-Go’

Humility and Impact in Joe McDonough’s Blood Cancer Heroes Experience

Trending on CURE

Cancer Vaccine Plus Keytruda Reduces Melanoma Recurrence or Death

How A Cancer Vaccine and Keytruda Work to Treat Patients With Melanoma

Blood Test May Predict Imdelltra Benefit in Small Cell Lung Cancer

Active Lifestyle Changes Following an MDS Diagnosis

How Ikebana Helped Me Navigate Life With Cancer